UnitedHealth Group (UNH) has staged a remarkable recovery from its August lows that followed a brutal year of regulatory scrutiny, cyberattack disruptions, Medicare reimbursement cuts, and an executive assassination.
Once a Wall Street darling, the stock stumbled amid these headwinds, erasing gains and testing investor patience. Yet, amid the rubble, UNH emerges as the most undervalued gem in healthcare – a sector brimming with innovation and demographic tailwinds. Trading at levels unseen since 2020-2021, this could mark the inflection point.
This post originally appeared at Money Morning.